# Patheon Inc. · 66-66 · CANADA — FDA import alert red lists: firms subject to detention without physical examination For Patheon Inc. · 66-66 · CANADA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CANADA; product is Synalar | Synalar; product code is 53 L - - 07 Night (Skin Care Preparations) | 55 Q - - 22 Polyethylene Glycol 1500 (Pharmaceutic Necessity - Ointment Base); date published is 09/30/2009; address is 2100 Syntex Crt , Mississauga, Ontario CANADA, verified against its source on 2026-09-16. - **Firm:** Patheon Inc. _(verified: appears in the quote below)_ - **Import alert:** 66-66 - **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122" - **Country:** CANADA _(verified: appears in the quote below)_ - **Address:** 2100 Syntex Crt , Mississauga, Ontario CANADA _(verified: appears in the quote below)_ - **Date published:** 09/30/2009 _(verified: appears in the quote below)_ - **Product code:** 53 L - - 07 Night (Skin Care Preparations) | 55 Q - - 22 Polyethylene Glycol 1500 (Pharmaceutic Necessity - Ointment Base) _(verified: each item appears in the quote below)_ - **Product:** Synalar | Synalar _(verified: each item appears in the quote below)_ - **FDA notes:** 11/2/2000 | 11/2/2000 _(verified: each item appears in the quote below)_ ## What the source says > Patheon Inc. Date Published : 09/30/2009 2100 Syntex Crt , Mississauga, Ontario CANADA 53 L - - 07 Night (Skin Care Preparations) Date Published: 04/02/2019 Desc: Synalar Notes: 11/2/2000 55 Q - - 22 Polyethylene Glycol 1500 (Pharmaceutic Necessity - Ointment Base) Date Published: 04/02/2019 Desc: Synalar Notes: 11/2/2000 ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_202.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).